Every drug should be adequately tested before coming on the market. Evidence should rule: The FDA must uphold scientific standards and not acquiesce to advocacy groups with an agenda, write guest columnists Caroline Renko, the project manager of PharmedOut, a prescribing research and education project at Georgetown University Medical Center, Judy Butler, senior research fellow at PharmedOut and Dr. Adriane Fugh-Berman, director of the project and a Georgetown Medical Center professor.
Watch/Read More
Categories